Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A

British Journal of Cancer

Volumn 86, Issue 6, 2002, Pages 993-998

  Vacca, A ^a   Bruno, M ^a   Boccarelli, A ^a   Coluccia, M ^a   Ribatti, D ^a   Bergamo, A ^b   Garbisa, S ^c   Sartor, L ^c   Sava, G ^b,d  

^a UNIVERSITY OF BARI   (Italy)

^b Callerio Foundation   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Angiogenesis; Chemotaxis; Endothelial cell; MMPs; Ruthenium

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIMETASTATIC AGENT; GELATINASE A; IMIDAZOLIUM IMIDAZOLEDIMETHYLSULFOXIDE TETRACHLORORUTHENATE; NAMI-A; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CHEMOTAXIS; CHICK EMBRYO; CHORIOALLANTOIS; DOSE RESPONSE; EMBRYO; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; CHEMOTAXIS; DIMETHYL SULFOXIDE; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM METASTASIS; ORGANOMETALLIC COMPOUNDS;

EID: 0037128713     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600176     Document Type: Article

References (29)

1. In vitro cell cycle arrest in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin
2. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
3. Angiogenesis in cancer and other disease
4. Interactions of metallopharmaceuticals with DNA
5. Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice
6. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
7. Permanent cell line expressing human factor VIII-related antigen established by hybridisation
8. The role of fibroblasts in tumor behavior
9. New tumor-inhibiting metal complexes
10. Role of laminin and basement membrane in the differentiation of endothelial cells into capillary-like structure
11. Quantification of cells cultured on 96-well plates
12. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
13. Biology and biochemistry of proteinases in tumor invasion
14. The role of proteinases in cellular invasiveness
15. Trophic factors and central nervous system metastasis
16. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment
17. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane
18. Interaction of angiogenic basic fibroblast growth factor with endothelial heparan sulfate proteoglycans. Biological implications in neovascularisation
19. Sulfoxide ruthenium complexes: Non-toxic tools for the selective treatment of solid tumour metastases
20. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex
21. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex
22. 4(DMSO)Im]: Mechanism of the selective action investigated on mouse tumours
23. 4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice
24. Proteolytic degradation of extracellular matrix in tumor invasion
25. Antiangiogenesis is produced by non-toxic doses of vinblastine
26. The cystein switch: A principle of regulation of metalloproteases activity with potential applicability to the entire matrix metalloproteinase gene family
27. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
28. 2-M cell fraction and inhibition of matrigel invasion, may predict in vivo-selective antimetastasis activity of ruthenium complexes